| scholarly article | Q13442814 |
| P50 | author | Dirk Dittmer | Q71109132 |
| P2093 | author name string | Haase A | |
| Staskus K | |||
| Ganem D | |||
| Lagunoff M | |||
| Renne R | |||
| P2860 | cites work | The prevalence of serum antibody to human herpesvirus 8 (Kaposi sarcoma-associated herpesvirus) among HIV-seropositive and high-risk HIV-seronegative women | Q41128088 |
| Propagation of a human herpesvirus from AIDS-associated Kaposi's sarcoma | Q41134075 | ||
| Antibodies to butyrate-inducible antigens of Kaposi's sarcoma-associated herpesvirus in patients with HIV-1 infection. | Q41198290 | ||
| Lytic growth of Kaposi's sarcoma-associated herpesvirus (human herpesvirus 8) in culture | Q41225141 | ||
| Cyclin encoded by KS herpesvirus | Q42633290 | ||
| Identification of the gene encoding the major latency-associated nuclear antigen of the Kaposi's sarcoma-associated herpesvirus | Q24561400 | ||
| Genomic sequencing | Q24594942 | ||
| Nucleotide sequence of the Kaposi sarcoma-associated herpesvirus (HHV8) | Q24650427 | ||
| The 222- to 234-kilodalton latent nuclear protein (LNA) of Kaposi's sarcoma-associated herpesvirus (human herpesvirus 8) is encoded by orf73 and is a component of the latency-associated nuclear antigen | Q24672438 | ||
| Identification of herpesvirus-like DNA sequences in AIDS-associated Kaposi's sarcoma | Q28242984 | ||
| A novel cyclin encoded by a bcl1-linked candidate oncogene | Q28268235 | ||
| Detection of herpesvirus-like DNA sequences in Kaposi's sarcoma in patients with and without HIV infection | Q28299060 | ||
| Kaposi's sarcoma-associated herpesvirus-like DNA sequences in AIDS-related body-cavity-based lymphomas | Q28299069 | ||
| At least six nucleotides preceding the AUG initiator codon enhance translation in mammalian cells | Q29618360 | ||
| Kaposi's sarcoma-associated herpesvirus-like DNA sequences in multicentric Castleman's disease | Q29619158 | ||
| Identification of a major latent nuclear antigen, LNA-1, in the human herpesvirus 8 genome | Q30668836 | ||
| Expression of Human Herpesvirus 8-Encoded Cyclin D in Kaposi's Sarcoma Spindle Cells | Q32163310 | ||
| Transcription Mapping of the Kaposi’s Sarcoma-Associated Herpesvirus (Human Herpesvirus 8) Genome in a Body Cavity-Based Lymphoma Cell Line (BC-1) | Q34069105 | ||
| Seroconversion to antibodies against Kaposi's sarcoma-associated herpesvirus-related latent nuclear antigens before the development of Kaposi's sarcoma | Q34383343 | ||
| The seroepidemiology of human herpesvirus 8 (Kaposi's sarcoma-associated herpesvirus): distribution of infection in KS risk groups and evidence for sexual transmission | Q34388952 | ||
| Kaposi's sarcoma-associated herpesvirus contains G protein-coupled receptor and cyclin D homologs which are expressed in Kaposi's sarcoma and malignant lymphoma | Q35872949 | ||
| Characterization of ribonucleoprotein complexes containing an abundant polyadenylated nuclear RNA encoded by Kaposi's sarcoma-associated herpesvirus (human herpesvirus 8) | Q35876734 | ||
| Cell-homologous genes in the Kaposi's sarcoma-associated rhadinovirus human herpesvirus 8: determinants of its pathogenicity? | Q35885806 | ||
| Human herpesvirus-8/Kaposi's sarcoma-associated herpesvirus is a new transmissible virus that infects B cells | Q36366617 | ||
| Viral FLICE-inhibitory proteins (FLIPs) prevent apoptosis induced by death receptors | Q36852093 | ||
| Restricted expression of Kaposi sarcoma-associated herpesvirus (human herpesvirus 8) genes in Kaposi sarcoma | Q37535731 | ||
| Limited Transmission of Kaposi’s Sarcoma-Associated Herpesvirus in Cultured Cells | Q39580911 | ||
| The size and conformation of Kaposi's sarcoma-associated herpesvirus (human herpesvirus 8) DNA in infected cells and virions | Q39877021 | ||
| Kaposi's sarcoma-associated herpesvirus gene expression in endothelial (spindle) tumor cells | Q39877852 | ||
| Kaposi's sarcoma-associated herpesvirus encodes a functional cyclin. | Q39878517 | ||
| The cyclin encoded by Kaposi's sarcoma-associated herpesvirus stimulates cdk6 to phosphorylate the retinoblastoma protein and histone H1. | Q39879780 | ||
| Epstein-Barr virus strategy in normal and neoplastic B cells | Q40657378 | ||
| Detection of Kaposi sarcoma associated herpesvirus in peripheral blood of HIV-infected individuals and progression to Kaposi's sarcoma | Q40972068 | ||
| Herpes viral cyclin/Cdk6 complexes evade inhibition by CDK inhibitor proteins. | Q41079253 | ||
| The Structure and Coding Organization of the Genomic Termini of Kaposi's Sarcoma-Associated Herpesvirus (Human Herpesvirus 8) | Q41090568 | ||
| P433 | issue | 10 | |
| P304 | page(s) | 8309-8315 | |
| P577 | publication date | 1998-10-01 | |
| P1433 | published in | Journal of Virology | Q1251128 |
| P1476 | title | A cluster of latently expressed genes in Kaposi's sarcoma-associated herpesvirus | |
| P478 | volume | 72 |
| Q41927566 | 1, 25(OH)2 D3 Induces Reactivation and Death of Kaposi's Sarcoma-Associated Herpesvirus of Primary Effusion Lymphoma cells |
| Q39756815 | A Domain in the C-terminal region of latency-associated nuclear antigen 1 of Kaposi's sarcoma-associated Herpesvirus affects transcriptional activation and binding to nuclear heterochromatin |
| Q35382266 | A Kaposi's Sarcoma-Associated Herpesvirus-Encoded Ortholog of MicroRNA miR-155 Induces Human Splenic B-Cell Expansion in NOD/LtSz-scid IL2Rγ null Mice |
| Q37245887 | A Purine Scaffold HSP90 Inhibitor BIIB021 Has Selective Activity against KSHV-Associated Primary Effusion Lymphoma and Blocks vFLIP K13-Induced NF-κB |
| Q40605014 | A Role for the Internal Repeat of the Kaposi's Sarcoma-Associated Herpesvirus Latent Nuclear Antigen in the Persistence of an Episomal Viral Genome |
| Q35791222 | A cluster of transcripts encoded by KSHV ORF30-33 gene locus |
| Q34547697 | A combined computational and microarray-based approach identifies novel microRNAs encoded by human gamma-herpesviruses |
| Q33815534 | A complex translational program generates multiple novel proteins from the latently expressed kaposin (K12) locus of Kaposi's sarcoma-associated herpesvirus. |
| Q34280032 | A computational profiling of changes in gene expression and transcription factors induced by vFLIP K13 in primary effusion lymphoma |
| Q37523519 | A critical Sp1 element in the rhesus rhadinovirus (RRV) Rta promoter confers high-level activity that correlates with cellular permissivity for viral replication |
| Q34490029 | A microRNA Encoded by Kaposi Sarcoma-Associated Herpesvirus Promotes B-Cell Expansion In Vivo |
| Q37288983 | A role for host activation-induced cytidine deaminase in innate immune defense against KSHV. |
| Q34100180 | A systems biology approach identified different regulatory networks targeted by KSHV miR-K12-11 in B cells and endothelial cells |
| Q38394187 | APOBECs and virus restriction |
| Q36845797 | Activation of Akt through gp130 receptor signaling is required for Kaposi's sarcoma-associated herpesvirus-induced lymphatic reprogramming of endothelial cells |
| Q26743368 | Activation of DNA Damage Response Induced by the Kaposi's Sarcoma-Associated Herpes Virus |
| Q33843421 | Activation of the Kaposi's sarcoma-associated herpesvirus major latency locus by the lytic switch protein RTA (ORF50). |
| Q34541350 | Altering the Anti-inflammatory Lipoxin Microenvironment: a New Insight into Kaposi's Sarcoma-Associated Herpesvirus Pathogenesis |
| Q33717717 | An Sp1 response element in the Kaposi's sarcoma-associated herpesvirus open reading frame 50 promoter mediates lytic cycle induction by butyrate |
| Q38700640 | An easily transfectable cell line that produces an infectious reporter virus for routine and robust quantitation of Kaposi's sarcoma-associated herpesvirus reactivation. |
| Q40344541 | An internal ribosome entry site directs translation of the murine gammaherpesvirus 68 MK3 open reading frame. |
| Q33809466 | Analysis of gene expression in a human cell line stably transduced with herpesvirus saimiri |
| Q33920506 | Analysis of transcripts from predicted open reading frames of Musca domestica salivary gland hypertrophy virus. |
| Q39729318 | Array-based transcript profiling and limiting-dilution reverse transcription-PCR analysis identify additional latent genes in Kaposi's sarcoma-associated herpesvirus |
| Q39992227 | Autoregulation of DNA binding and protein stability of Kaposi's sarcoma-associated herpesvirus ORF50 protein |
| Q33798426 | BALB/c mice immunized with a combination of virus-like particles incorporating Kaposi sarcoma-associated herpesvirus (KSHV) envelope glycoproteins gpK8.1, gB, and gH/gL induced comparable serum neutralizing antibody activity to UV-inactivated KSHV. |
| Q36559926 | CTCF regulates Kaposi's sarcoma-associated herpesvirus latency transcription by nucleosome displacement and RNA polymerase programming |
| Q39365643 | Cdk1 Inhibition Induces Mutually Inhibitory Apoptosis and Reactivation of Kaposi's Sarcoma-Associated Herpesvirus |
| Q39864214 | Cell cycle regulation by Kaposi's sarcoma-associated herpesvirus K-bZIP: direct interaction with cyclin-CDK2 and induction of G1 growth arrest. |
| Q33641552 | Characterization and cell cycle regulation of the major Kaposi's sarcoma-associated herpesvirus (human herpesvirus 8) latent genes and their promoter |
| Q33814510 | Characterization of monoclonal antibodies raised against the latent nuclear antigen of human herpesvirus 8 |
| Q33781363 | Characterization of the minimal replicator of Kaposi's sarcoma-associated herpesvirus latent origin |
| Q34340317 | Charting latency transcripts in Kaposi's sarcoma-associated herpesvirus by whole-genome real-time quantitative PCR |
| Q39789061 | Chromatin Immunoprecipitation and Microarray Analysis Suggest Functional Cooperation between Kaposi's Sarcoma-Associated Herpesvirus ORF57 and K-bZIP |
| Q33729584 | Chromatin organization of gammaherpesvirus latent genomes |
| Q36538689 | Chromatin remodeling of the Kaposi's sarcoma-associated herpesvirus ORF50 promoter correlates with reactivation from latency |
| Q35237492 | Chromatinization of the KSHV Genome During the KSHV Life Cycle |
| Q58700278 | Circular DNA tumor viruses make circular RNAs |
| Q33883910 | Cloning and identification of a microRNA cluster within the latency-associated region of Kaposi's sarcoma-associated herpesvirus |
| Q41947834 | Cohesins Repress Kaposi's Sarcoma-Associated Herpesvirus Immediate Early Gene Transcription during Latency |
| Q40020777 | Cohesins localize with CTCF at the KSHV latency control region and at cellular c-myc and H19/Igf2 insulators |
| Q40815022 | Comparison of the Rta/Orf50 transactivator proteins of gamma-2-herpesviruses. |
| Q37336432 | Comprehensive mapping and analysis of Kaposi's sarcoma-associated herpesvirus 3' UTRs identify differential posttranscriptional control of gene expression in lytic versus latent infection. |
| Q89899078 | Concurrent Control of KSHV Life Cycle through Chromatin Modulation and Host Hedgehog Signaling: A New Prospect to the Therapeutic Potential of Lipoxin A4 |
| Q34005284 | Coordination of KSHV Latent and Lytic Gene Control by CTCF-Cohesin Mediated Chromosome Conformation |
| Q34106764 | Coupled transcriptome and proteome analysis of human lymphotropic tumor viruses: insights on the detection and discovery of viral genes |
| Q40041231 | Cross-species conservation of episome maintenance provides a basis for in vivo investigation of Kaposi's sarcoma herpesvirus LANA. |
| Q33853499 | DNA binding and modulation of gene expression by the latency-associated nuclear antigen of Kaposi's sarcoma-associated herpesvirus |
| Q39602154 | Differential regulation of the overlapping Kaposi's sarcoma-associated herpesvirus vGCR (orf74) and LANA (orf73) promoters |
| Q41891421 | Disruption of LANA in rhesus rhadinovirus generates a highly lytic recombinant virus |
| Q38115771 | Distinct Roles of Kaposi's Sarcoma-Associated Herpesvirus-Encoded Viral Interferon Regulatory Factors in Inflammatory Response and Cancer |
| Q35131811 | Distribution of human herpesvirus-8 latently infected cells in Kaposi's sarcoma, multicentric Castleman's disease, and primary effusion lymphoma |
| Q36258923 | Epigenetic Landscape of Kaposi's Sarcoma-Associated Herpesvirus Genome in Classic Kaposi's Sarcoma Tissues |
| Q90702448 | Epigenetic control in Kaposi sarcoma-associated herpesvirus infection and associated disease |
| Q34124015 | Establishment and maintenance of Kaposi's sarcoma-associated herpesvirus latency in B cells |
| Q36911706 | Ets-1 is required for the activation of VEGFR3 during latent Kaposi's sarcoma-associated herpesvirus infection of endothelial cells. |
| Q34089478 | Evolutionary aspects of oncogenic herpesviruses |
| Q36375588 | Experimental transmission of Kaposi's sarcoma-associated herpesvirus (KSHV/HHV-8) to SCID-hu Thy/Liv mice |
| Q38727204 | Expression of the Antisense-to-Latency Transcript Long Noncoding RNA in Kaposi's Sarcoma-Associated Herpesvirus |
| Q33815875 | Expression of the open reading frame 74 (G-protein-coupled receptor) gene of Kaposi's sarcoma (KS)-associated herpesvirus: implications for KS pathogenesis |
| Q41924146 | Full-Length Isoforms of Kaposi's Sarcoma-Associated Herpesvirus Latency-Associated Nuclear Antigen Accumulate in the Cytoplasm of Cells Undergoing the Lytic Cycle of Replication |
| Q34363927 | Functional analysis of Kaposi's sarcoma-associated herpesvirus vFLIP expression reveals a new mode of IRES-mediated translation |
| Q35635426 | Functional p53 signaling in Kaposi's sarcoma-associated herpesvirus lymphomas: implications for therapy. |
| Q35184458 | Gamma herpesviruses: pathogenesis of infection and cell signaling |
| Q37060535 | Genetic disruption of KSHV major latent nuclear antigen LANA enhances viral lytic transcriptional program |
| Q34717873 | Genetic organization and hypoxic activation of the Kaposi's sarcoma-associated herpesvirus ORF34-37 gene cluster |
| Q37547788 | Genomewide mapping and screening of Kaposi's sarcoma-associated herpesvirus (KSHV) 3' untranslated regions identify bicistronic and polycistronic viral transcripts as frequent targets of KSHV microRNAs |
| Q40176573 | Herpesvirus saimiri episomal persistence is maintained via interaction between open reading frame 73 and the cellular chromosome-associated protein MeCP2. |
| Q39593823 | Herpesvirus saimiri vFLIP provides an antiapoptotic function but is not essential for viral replication, transformation, or pathogenicity |
| Q35787282 | High expression of HHV-8-encoded ORF73 protein in spindle-shaped cells of Kaposi's sarcoma |
| Q33295395 | Host transcript accumulation during lytic KSHV infection reveals several classes of host responses |
| Q92295697 | How Kaposi's sarcoma-associated herpesvirus stably transforms peripheral B cells towards lymphomagenesis |
| Q24527215 | Human herpesvirus 8 LANA interacts with proteins of the mSin3 corepressor complex and negatively regulates Epstein-Barr virus gene expression in dually infected PEL cells |
| Q38343657 | Human herpesvirus 8 viral FLICE-inhibitory protein retards cell proliferation via downregulation of Id2 and Id3 expression |
| Q54111927 | Human herpesvirus-encoded kinase induces B cell lymphomas in vivo. |
| Q37383464 | Identification of an Rta responsive promoter involved in driving gammaHV68 v-cyclin expression during virus replication |
| Q33801927 | Identification of antigenic proteins encoded by human herpesvirus 8 and seroprevalence in the general population and among patients with and without Kaposi's sarcoma |
| Q21131610 | Identification of cellular genes targeted by KSHV-encoded microRNAs |
| Q34353305 | Identification of spliced gammaherpesvirus 68 LANA and v-cyclin transcripts and analysis of their expression in vivo during latent infection |
| Q34795543 | Immune Evasion by Kaposi‘s Sarcoma-Associated Herpesvirus |
| Q35745497 | Induction of HHV-8 lytic cycle replication by inflammatory cytokines produced by HIV-1-infected T cells |
| Q33843211 | Induction of Kaposi's sarcoma-associated herpesvirus latency-associated nuclear antigen by the lytic transactivator RTA: a novel mechanism for establishment of latency |
| Q33648926 | Induction of protective immunity against murine gammaherpesvirus 68 infection in the absence of viral latency |
| Q35758587 | Inefficient Codon Usage Impairs mRNA Accumulation: the Case of the v-FLIP Gene of Kaposi's Sarcoma-Associated Herpesvirus |
| Q40589924 | Inflammatory cytokines inhibit Kaposi's sarcoma-associated herpesvirus lytic gene transcription in in vitro-infected endothelial cells |
| Q27486093 | Inhibition of replication and transcription activator and latency-associated nuclear antigen of Kaposi's sarcoma-associated herpesvirus by morpholino oligomers |
| Q41886930 | Interaction of Adenovirus E1A with the HHV8 Promoter of Latent Genes: E1A Proteins are Able to Activate the HHV-8 LANAp in MV3 Reporter Cells |
| Q39610285 | Internal ribosome entry site regulates translation of Kaposi's sarcoma-associated herpesvirus FLICE inhibitory protein |
| Q34615002 | Interplay between Kaposi's sarcoma-associated herpesvirus and the innate immune system |
| Q37410861 | Involvement of SSRP1 in latent replication of Kaposi's sarcoma-associated herpesvirus |
| Q37488130 | KSHV 2.0: a comprehensive annotation of the Kaposi's sarcoma-associated herpesvirus genome using next-generation sequencing reveals novel genomic and functional features |
| Q26766437 | KSHV Genome Replication and Maintenance |
| Q34774797 | KSHV LANA--the master regulator of KSHV latency |
| Q41662283 | KSHV and the Role of Notch Receptor Dysregulation in Disease Progression |
| Q33761091 | KSHV and the pathogenesis of Kaposi sarcoma: listening to human biology and medicine |
| Q37237030 | KSHV encoded LANA recruits Nucleosome Assembly Protein NAP1L1 for regulating viral DNA replication and transcription |
| Q38692823 | KSHV encoded ORF59 modulates histone arginine methylation of the viral genome to promote viral reactivation |
| Q34423454 | KSHV miRNAs decrease expression of lytic genes in latently infected PEL and endothelial cells by targeting host transcription factors |
| Q28474913 | KSHV reactivation from latency requires Pim-1 and Pim-3 kinases to inactivate the latency-associated nuclear antigen LANA |
| Q33955300 | KSHV vCyclin counters the senescence/G1 arrest response triggered by NF-κB hyperactivation |
| Q27026000 | KSHV: pathways to tumorigenesis and persistent infection |
| Q35127940 | Kaposi sarcoma-associated herpesvirus (KSHV): molecular biology and oncogenesis |
| Q33748042 | Kaposi sarcoma-associated herpesvirus latency-associated nuclear antigen inhibits interferon (IFN) beta expression by competing with IFN regulatory factor-3 for binding to IFNB promoter |
| Q37016504 | Kaposi sarcoma-associated herpesvirus/human herpesvirus 8 and lymphoproliferative disorders |
| Q26738483 | Kaposi's Sarcoma Herpesvirus Genome Persistence |
| Q90319829 | Kaposi's Sarcoma-Associated Herpesvirus (KSHV)-Associated Disease in the AIDS Patient: An Update |
| Q35665756 | Kaposi's Sarcoma-Associated Herpesvirus Latency-Associated Nuclear Antigen Induction by Hypoxia and Hypoxia-Inducible Factors |
| Q39265271 | Kaposi's Sarcoma-Associated Herpesvirus Latency-Associated Nuclear Antigen: Replicating and Shielding Viral DNA during Viral Persistence |
| Q35192868 | Kaposi's Sarcoma-Associated Herpesvirus-Encoded Latency-Associated Nuclear Antigen Reduces Interleukin-8 Expression in Endothelial Cells and Impairs Neutrophil Chemotaxis by Degrading Nuclear p65 |
| Q28472867 | Kaposi's sarcoma associated herpes virus (KSHV) induced COX-2: a key factor in latency, inflammation, angiogenesis, cell survival and invasion |
| Q41846091 | Kaposi's sarcoma-associated herpesvirus LANA protein downregulates nuclear glycogen synthase kinase 3 activity and consequently blocks differentiation |
| Q33834993 | Kaposi's sarcoma-associated herpesvirus LANA2 is a B-cell-specific latent viral protein that inhibits p53 |
| Q39940851 | Kaposi's sarcoma-associated herpesvirus RTA activates the processivity factor ORF59 through interaction with RBP-Jkappa and a cis-acting RTA responsive element. |
| Q39860632 | Kaposi's sarcoma-associated herpesvirus RTA promotes degradation of the Hey1 repressor protein through the ubiquitin proteasome pathway |
| Q24555724 | Kaposi's sarcoma-associated herpesvirus expresses an array of viral microRNAs in latently infected cells |
| Q38305362 | Kaposi's sarcoma-associated herpesvirus latent and lytic gene expression as revealed by DNA arrays |
| Q36540187 | Kaposi's sarcoma-associated herpesvirus latent gene vFLIP inhibits viral lytic replication through NF-kappaB-mediated suppression of the AP-1 pathway: a novel mechanism of virus control of latency |
| Q33807199 | Kaposi's sarcoma-associated herpesvirus open reading frame 50/Rta protein activates the entire viral lytic cycle in the HH-B2 primary effusion lymphoma cell line |
| Q33737793 | Kaposi's sarcoma-associated herpesvirus reactivation is regulated by interaction of latency-associated nuclear antigen with recombination signal sequence-binding protein Jkappa, the major downstream effector of the Notch signaling pathway |
| Q24529088 | Kaposi's sarcoma-associated herpesvirus vCyclin open reading frame contains an internal ribosome entry site |
| Q91790329 | Kaposi's sarcoma-associated herpesvirus vIRF2 protein utilizes an IFN-dependent pathway to regulate viral early gene expression |
| Q40607781 | Kaposi's sarcoma-associated herpesvirus-encoded LANA can induce chromosomal instability through targeted degradation of the mitotic checkpoint kinase Bub1 |
| Q34346925 | Kinetics of expression of rhesus monkey rhadinovirus (RRV) and identification and characterization of a polycistronic transcript encoding the RRV Orf50/Rta, RRV R8, and R8.1 genes. |
| Q28540872 | LANA binds to multiple active viral and cellular promoters and associates with the H3K4methyltransferase hSET1 complex |
| Q36126100 | LANA-Mediated Recruitment of Host Polycomb Repressive Complexes onto the KSHV Genome during De Novo Infection |
| Q37252649 | Latency locus complements MicroRNA 155 deficiency in vivo. |
| Q40317413 | Latency-associated nuclear antigen (LANA) of Kaposi's sarcoma-associated herpesvirus interacts with origin recognition complexes at the LANA binding sequence within the terminal repeats |
| Q24670086 | Latency-associated nuclear antigen of Kaposi's sarcoma-associated herpesvirus recruits uracil DNA glycosylase 2 at the terminal repeats and is important for latent persistence of the virus |
| Q36223625 | Linking KSHV to human cancer |
| Q33817882 | Long-term infection and transformation of dermal microvascular endothelial cells by human herpesvirus 8. |
| Q40287215 | Long-term-infected telomerase-immortalized endothelial cells: a model for Kaposi's sarcoma-associated herpesvirus latency in vitro and in vivo |
| Q35363036 | Mechanism of Glycyrrhizic Acid Inhibition of Kaposi's Sarcoma-Associated Herpesvirus: Disruption of CTCF-Cohesin-Mediated RNA Polymerase II Pausing and Sister Chromatid Cohesion |
| Q39602182 | Mechanisms governing expression of the v-FLIP gene of Kaposi's sarcoma-associated herpesvirus |
| Q35010647 | Mechanisms of Kaposi's Sarcoma-Associated Herpesvirus Latency and Reactivation |
| Q92327692 | Mechanistic Insights into Chemoresistance Mediated by Oncogenic Viruses in Lymphomas |
| Q47547495 | Modified cross-linking, ligation, and sequencing of hybrids (qCLASH) identifies KSHV microRNA targets in endothelial cells |
| Q92238951 | Modulation of Angiogenic Processes by the Human Gammaherpesviruses, Epstein-Barr Virus and Kaposi's Sarcoma-Associated Herpesvirus |
| Q35801076 | Modulation of Immune System by Kaposi’s Sarcoma-Associated Herpesvirus: Lessons from Viral Evasion Strategies |
| Q33835021 | Modulation of cellular and viral gene expression by the latency-associated nuclear antigen of Kaposi's sarcoma-associated herpesvirus |
| Q90319823 | Molecular Biology of KSHV in Relation to HIV/AIDS-Associated Oncogenesis |
| Q35124404 | Molecular Biology of Kaposi's Sarcoma-associated Herpesvirus and Related Oncogenesis |
| Q33560572 | Molecular biology of KSHV in relation to AIDS-associated oncogenesis |
| Q35026060 | Molecular genetics of Kaposi's sarcoma-associated herpesvirus (human herpesvirus-8) epidemiology and pathogenesis |
| Q28363323 | Molecular virology of Kaposi's sarcoma-associated herpesvirus |
| Q35641125 | Murine Gammaherpesvirus 68 ORF48 Is an RTA-Responsive Gene Product and Functions in both Viral Lytic Replication and Latency during In Vivo Infection |
| Q36363318 | Murine gammaherpesvirus 68 LANA acts on terminal repeat DNA to mediate episome persistence |
| Q33966678 | Murine gammaherpesvirus 68 LANA is essential for virus reactivation from splenocytes but not long-term carriage of viral genome |
| Q33808932 | Murine gammaherpesvirus 68 cyclin D homologue is required for efficient reactivation from latency |
| Q38335076 | Mutation of a C-terminal motif affects Kaposi's sarcoma-associated herpesvirus ORF57 RNA binding, nuclear trafficking, and multimerization |
| Q39688916 | Myc is required for the maintenance of Kaposi's sarcoma-associated herpesvirus latency |
| Q37374081 | NF-κB as a Target for Oncogenic Viruses |
| Q26752599 | Next-Generation Sequencing in the Understanding of Kaposi's Sarcoma-Associated Herpesvirus (KSHV) Biology |
| Q36252859 | Nuclear Localization and Cleavage of STAT6 Is Induced by Kaposi's Sarcoma-Associated Herpesvirus for Viral Latency |
| Q39105335 | Nuclear factor kappa B is required for the production of infectious human herpesvirus 8 virions |
| Q33545232 | Nucleophosmin phosphorylation by v-cyclin-CDK6 controls KSHV latency |
| Q40276488 | ORC, MCM, and histone hyperacetylation at the Kaposi's sarcoma-associated herpesvirus latent replication origin |
| Q40173321 | ORF73 of Herpesvirus Saimiri Strain C488 Tethers the Viral Genome to Metaphase Chromosomes and Binds to cis -Acting DNA Sequences in the Terminal Repeats |
| Q34311582 | Opposing regulation of PROX1 by interleukin-3 receptor and NOTCH directs differential host cell fate reprogramming by Kaposi sarcoma herpes virus. |
| Q42166459 | Oxidative Stress Induces Reactivation of Kaposi's Sarcoma-Associated Herpesvirus and Death of Primary Effusion Lymphoma Cells |
| Q34333321 | Patterns of gene expression and a transactivation function exhibited by the vGCR (ORF74) chemokine receptor protein of Kaposi's sarcoma-associated herpesvirus |
| Q39959766 | Poly(ADP-ribose) polymerase 1 binds to Kaposi's sarcoma-associated herpesvirus (KSHV) terminal repeat sequence and modulates KSHV replication in latency |
| Q33432690 | Pre-micro RNA signatures delineate stages of endothelial cell transformation in Kaposi sarcoma. |
| Q36736361 | Primary B Lymphocytes Infected with Kaposi's Sarcoma-Associated Herpesvirus Can Be Expanded In Vitro and Are Recognized by LANA-Specific CD4+ T Cells |
| Q37780705 | Prospects of a novel vaccination strategy for human gamma-herpesviruses |
| Q37727998 | Quantitative Analysis of the KSHV Transcriptome Following Primary Infection of Blood and Lymphatic Endothelial Cells |
| Q60952467 | Quantitative RNAseq analysis of Ugandan KS tumors reveals KSHV gene expression dominated by transcription from the LTd downstream latency promoter |
| Q39323914 | Quantitative analysis of the bidirectional viral G-protein-coupled receptor and lytic latency-associated nuclear antigen promoter of Kaposi's sarcoma-associated herpesvirus. |
| Q24673299 | Rapamycin is efficacious against primary effusion lymphoma (PEL) cell lines in vivo by inhibiting autocrine signaling |
| Q35458156 | Restricted Kaposi’s Sarcoma (KS) Herpesvirus Transcription in KS Lesions from Patients on Successful Antiretroviral Therapy |
| Q36969847 | Rhesus macaque rhadinovirus-associated non-Hodgkin lymphoma: animal model for KSHV-associated malignancies |
| Q38319392 | Role of Notch signal transduction in Kaposi's sarcoma-associated herpesvirus gene expression |
| Q35857793 | Signaling cascades triggered by bacterial metabolic end products during reactivation of Kaposi's sarcoma-associated herpesvirus |
| Q35125136 | Split genes and their expression in Kaposi's sarcoma‐associated herpesvirus |
| Q35124429 | Structure and function of latency-associated nuclear antigen |
| Q52722164 | Superresolution microscopy reveals structural mechanisms driving the nanoarchitecture of a viral chromatin tether |
| Q30311122 | Surface downregulation of major histocompatibility complex class I, PE-CAM, and ICAM-1 following de novo infection of endothelial cells with Kaposi's sarcoma-associated herpesvirus |
| Q35024331 | Temporal transcription program of recombinant Autographa californica multiple nucleopolyhedrosis virus |
| Q34355898 | The Herpesvirus Saimiri open reading frame 73 gene product interacts with the cellular protein p32. |
| Q36433542 | The KSHV viral IL-6 homolog is sufficient to induce blood to lymphatic endothelial cell differentiation. |
| Q92689673 | The Kaposi's Sarcoma-Associated Herpesvirus ORF34 Protein Interacts and Stabilizes HIF-2α via Binding to the HIF-2α bHLH and PAS Domains |
| Q35066362 | The Kaposi's sarcoma-associated herpesvirus (KSHV)-induced 5-lipoxygenase-leukotriene B4 cascade plays key roles in KSHV latency, monocyte recruitment, and lipogenesis |
| Q34359380 | The Kaposi's sarcoma-associated herpesvirus K12 transcript from a primary effusion lymphoma contains complex repeat elements, is spliced, and initiates from a novel promoter |
| Q39230427 | The Kaposi's sarcoma-associated herpesvirus ORF34 protein binds to HIF-1α and causes its degradation via the proteasome pathway |
| Q34977304 | The Latency-Associated Nuclear Antigen Homolog of Herpesvirus Saimiri Inhibits Lytic Virus Replication |
| Q33872257 | The MARCH Family E3 Ubiquitin Ligase K5 Alters Monocyte Metabolism and Proliferation through Receptor Tyrosine Kinase Modulation |
| Q38722941 | The Viral Bcl-2 Homologs of Kaposi's Sarcoma-Associated Herpesvirus and Rhesus Rhadinovirus Share an Essential Role for Viral Replication. |
| Q33598569 | The epigenetic landscape of latent Kaposi sarcoma-associated herpesvirus genomes. |
| Q34391203 | The latency-associated nuclear antigen of Kaposi sarcoma-associated herpesvirus induces B cell hyperplasia and lymphoma |
| Q33834414 | The latency-associated nuclear antigen of rhesus monkey rhadinovirus inhibits viral replication through repression of Orf50/Rta transcriptional activation |
| Q34046103 | The lytic transcriptome of Kaposi's sarcoma-associated herpesvirus reveals extensive transcription of noncoding regions, including regions antisense to important genes. |
| Q40199723 | The minimal replicator element of the Kaposi's sarcoma-associated herpesvirus terminal repeat supports replication in a semiconservative and cell-cycle-dependent manner |
| Q33814440 | The murine gammaherpesvirus 68 v-cyclin gene is an oncogene that promotes cell cycle progression in primary lymphocytes |
| Q39592670 | The murine gammaherpesvirus 68 v-cyclin is a critical regulator of reactivation from latency. |
| Q37252776 | The open chromatin landscape of Kaposi's sarcoma-associated herpesvirus |
| Q24685892 | The viral etiology of AIDS-associated malignancies |
| Q33653581 | Three distinct regions of the murine gammaherpesvirus 68 genome are transcriptionally active in latently infected mice |
| Q34349469 | Tissue specificity of the Kaposi's sarcoma-associated herpesvirus latent nuclear antigen (LANA/orf73) promoter in transgenic mice |
| Q64247511 | Towards Better Understanding of KSHV Life Cycle: from Transcription and Posttranscriptional Regulations to Pathogenesis |
| Q33844645 | Transcription pattern of human herpesvirus 8 open reading frame K3 in primary effusion lymphoma and Kaposi's sarcoma. |
| Q33841257 | Transcription program of human herpesvirus 8 (kaposi's sarcoma-associated herpesvirus). |
| Q34434808 | Transcriptional origin of Kaposi's sarcoma-associated herpesvirus microRNAs |
| Q39612221 | Transcripts encoding K12, v-FLIP, v-cyclin, and the microRNA cluster of Kaposi's sarcoma-associated herpesvirus originate from a common promoter. |
| Q34411851 | Unbiased Mutagenesis of MHV68 LANA Reveals a DNA-Binding Domain Required for LANA Function In Vitro and In Vivo |
| Q34013770 | Upregulation of Cellular Bcl-2 by the KSHV Encoded RTA Promotes Virion Production |
| Q24799552 | Use of a multi-virus array for the study of human viral and retroviral pathogens: gene expression studies and ChIP-chip analysis |
| Q28079936 | Viral Inhibition of PRR-Mediated Innate Immune Response: Learning from KSHV Evasion Strategies |
| Q34039189 | Viral latency and its regulation: lessons from the gamma-herpesviruses |
| Q36761560 | Viral latency locus augments B-cell response in vivo to induce chronic marginal zone enlargement, plasma cell hyperplasia, and lymphoma. |
| Q34112086 | Viral miRNA targeting of bicistronic and polycistronic transcripts |
| Q34237734 | Viral profiling identifies multiple subtypes of Kaposi's sarcoma. |
| Q34092690 | beta-Adrenoreceptors reactivate Kaposi's sarcoma-associated herpesvirus lytic replication via PKA-dependent control of viral RTA |
| Q36745445 | mTOR Inhibitors Block Kaposi Sarcoma Growth by Inhibiting Essential Autocrine Growth Factors and Tumor Angiogenesis |
| Q39061575 | p53 tumor suppressor protein stability and transcriptional activity are targeted by Kaposi's sarcoma-associated herpesvirus-encoded viral interferon regulatory factor 3. |
Search more.